This report has described several currently evolving strategies and therapeutic agents designed to inhibit the complement system. Many others can be envisioned. Analagous to the utility of therapeutic agents that inhibit the coagulation cascade, it can be anticipated that complement inhibitors will find an important niche in our armamentarium of drugs to reduce undesirable inflammatory reactions.

Original languageEnglish
Pages (from-to)168-173
Number of pages6
JournalClinical Immunology Newsletter
Issue number12
StatePublished - Dec 1997


Dive into the research topics of 'Complement inhibitors as therapeutic agents'. Together they form a unique fingerprint.

Cite this